Goldman Sachs Group Inc Cerus Corp Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Cerus Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,376,565 shares of CERS stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,376,565
Previous 868,405
58.52%
Holding current value
$2.29 Million
Previous $1.53 Million
56.74%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CERS
# of Institutions
156Shares Held
147MCall Options Held
84.2KPut Options Held
55.5K-
Baker Bros. Advisors LP New York, NY19.5MShares$32.3 Million0.36% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$30.3 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$23.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$18 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.54MShares$14.2 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $294M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...